Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Identification of Streptococcus suis Meningitis through Population-Based Surveillance, Togo, 2010-2014.

Tall H, Njanpop-Lafourcade BM, Mounkoro D, Tidjani L, Agbenoko K, Alassani I, Amidou M, Tamekloe S, Laing KG, Witney AA, Hinds J, van der Linden MP, Gessner BD, Moïsi JC.

Emerg Infect Dis. 2016 Jul;22(7):1262-4. doi: 10.3201/eid2207.151511.

2.

The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens.

Messaoudi M, Milenkov M, Albrich WC, van der Linden MP, Bénet T, Chou M, Sylla M, Barreto Costa P, Richard N, Klugman KP, Endtz HP, Paranhos-Baccalà G, Telles JN.

PLoS One. 2016 Mar 17;11(3):e0151428. doi: 10.1371/journal.pone.0151428. eCollection 2016.

3.

Astrovirus outbreak at a pediatric hematology and hematopoietic stem cell transplant unit despite strict hygiene rules.

van der Doef HP, Bathoorn E, van der Linden MP, Wolfs TF, Minderhoud AL, Bierings MB, Wensing AM, Lindemans CA.

Bone Marrow Transplant. 2016 May;51(5):747-50. doi: 10.1038/bmt.2015.337. Epub 2016 Jan 25. No abstract available.

PMID:
26808571
4.

Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units.

Oliver MB, van der Linden MP, Küntzel SA, Saad JS, Nahm MH.

J Biol Chem. 2015 Oct 30;290(44):26474-5. doi: 10.1074/jbc.A113.480152. No abstract available.

5.

Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.

Knevel R, Klein K, Somers K, Ospelt C, Houwing-Duistermaat JJ, van Nies JA, de Rooy DP, de Bock L, Kurreeman FA, Schonkeren J, Stoeken-Rijsbergen G, Helmer Q, van der Linden MP, Kern M, Manjarrez-Orduno N, Rodriguez-Rodriquez L, Stinissen P, Huizinga TW, Toes RE, Gay S, Gregersen PK, Somers V, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Nov;73(11):2038-46. doi: 10.1136/annrheumdis-2013-204050. Epub 2013 Aug 16.

PMID:
23956247
6.

Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units.

Oliver MB, van der Linden MP, Küntzel SA, Saad JS, Nahm MH.

J Biol Chem. 2013 Sep 6;288(36):25976-85. doi: 10.1074/jbc.M113.480152. Epub 2013 Jul 29. Erratum in: J Biol Chem. 2015 Oct 30;290(44):26474-5.

7.

A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.

Knevel R, Krabben A, Wilson AG, Brouwer E, Leijsma MK, Lindqvist E, de Rooy DP, Daha NA, van der Linden MP, Tsonaka S, Zhernakova A, Westra HJ, Franke L, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Saxne T, van der Helm-van Mil AH.

Arthritis Rheum. 2013 Mar;65(3):582-9. doi: 10.1002/art.37808.

8.

Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis.

Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, Houwing-Duistermaat JJ, van der Helm-van Mil AH.

Scand J Rheumatol. 2013;42(3):182-9. doi: 10.3109/03009742.2012.728618. Epub 2013 Feb 20.

PMID:
23425151
9.

Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study.

Knevel R, Krabben A, Brouwer E, Posthumus MD, Wilson AG, Lindqvist E, Saxne T, de Rooy D, Daha N, van der Linden MP, Stoeken G, van Toorn L, Koeleman B, Tsonaka R, Zhernakoza A, Houwing-Duistermaat JJ, Toes R, Huizinga TW, van der Helm-van Mil A.

Ann Rheum Dis. 2012 Oct;71(10):1651-7. doi: 10.1136/annrheumdis-2011-200724. Epub 2012 Mar 22.

PMID:
22440823
10.

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17372-7. doi: 10.1073/pnas.1114465108. Epub 2011 Oct 10.

11.

Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis.

Scherer HU, van der Woude D, Willemze A, Trouw LA, Knevel R, Syversen SW, van der Linden MP, Lie B, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH, Kvien TK, Toes RE.

Ann Rheum Dis. 2011 Aug;70(8):1461-4. doi: 10.1136/ard.2010.146506. Epub 2011 Jun 10.

PMID:
21666230
12.

Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis.

Klein-Wieringa IR, van der Linden MP, Knevel R, Kwekkeboom JC, van Beelen E, Huizinga TW, van der Helm-van Mil A, Kloppenburg M, Toes RE, Ioan-Facsinay A.

Arthritis Rheum. 2011 Sep;63(9):2567-74. doi: 10.1002/art.30449.

13.

Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?

van der Linden MP, Batstra MR, Bakker-Jonges LE; Foundation for Quality Medical Laboratory Diagnostics, Detert J, Bastian H, Scherer HU, Toes RE, Burmester GR, Mjaavatten MD, Kvien TK, Huizinga TW, van der Helm-van Mil AH.

Arthritis Rheum. 2011 May;63(5):1190-9. doi: 10.1002/art.30200.

14.

The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics.

Willemze A, van der Linden MP, le Cessie S, Trouw LA, Toes RE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2011 Sep;70(9):1697-8. doi: 10.1136/ard.2010.148312. Epub 2011 Apr 10. No abstract available.

PMID:
21482537
15.

Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.

Meeuwisse CM, van der Linden MP, Rullmann TA, Allaart CF, Nelissen R, Huizinga TW, Garritsen A, Toes RE, van Schaik R, van der Helm-van Mil AH.

Arthritis Rheum. 2011 May;63(5):1265-73. doi: 10.1002/art.30273.

16.
17.

Long-term impact of delay in assessment of patients with early arthritis.

van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW, van der Helm-van Mil AH.

Arthritis Rheum. 2010 Dec;62(12):3537-46. doi: 10.1002/art.27692.

18.

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2011 Jan;50(1):93-100. doi: 10.1093/rheumatology/keq230. Epub 2010 Jul 16.

PMID:
20639266
19.

The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.

van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP, van der Helm-van Mil AH, van der Heijde DM, Huizinga TW, Kvien TK, Toes RE.

Ann Rheum Dis. 2010 Jun;69(6):1110-6. doi: 10.1136/ard.2009.116384. Epub 2010 May 3.

PMID:
20439289
20.

The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis.

van Nies JA, Knevel R, Daha N, van der Linden MP, Gregersen PK, Kern M, le Cessie S, Houwing-Duistermaat JJ, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Ann Rheum Dis. 2010 Sep;69(9):1730-1. doi: 10.1136/ard.2009.117952. Epub 2010 Apr 13. No abstract available.

21.

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.

22.

Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.

van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, Begovich AB, Chang M, Catanese JJ, Kurreeman FA, van Nies J, van der Heijde DM, Gregersen PK, Huizinga TW, Toes RE, van der Helm-Van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2242-7. doi: 10.1002/art.24721.

23.

Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort.

van der Linden MP, Boja R, Klarenbeek NB, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH.

Ann Rheum Dis. 2010 Apr;69(4):727-9. doi: 10.1136/ard.2009.108332. Epub 2009 May 18.

PMID:
19454405
24.

Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis.

Scherer HU, van der Linden MP, Kurreeman FA, Stoeken-Rijsbergen G, Cessie Sl, Huizinga TW, van der Helm-van Mil AH, Toes RE.

Ann Rheum Dis. 2010 Mar;69(3):567-70. doi: 10.1136/ard.2008.106161. Epub 2009 Apr 14.

25.

Site-directed mutagenesis of proposed active-site residues of penicillin-binding protein 5 from Escherichia coli.

van der Linden MP, de Haan L, Dideberg O, Keck W.

Biochem J. 1994 Oct 15;303 ( Pt 2):357-62.

26.
27.
28.

In vivo crystal formation in Escherichia coli of an over-expressed soluble form of penicillin-binding protein 5.

van der Linden MP, Vonck J, Sjollema KA, Keck W.

FEMS Microbiol Lett. 1992 Dec 1;78(2-3):117-23.

PMID:
1490594
29.

Possible role of Escherichia coli penicillin-binding protein 6 in stabilization of stationary-phase peptidoglycan.

van der Linden MP, de Haan L, Hoyer MA, Keck W.

J Bacteriol. 1992 Dec;174(23):7572-8.

32.
33.

[Is there in Belgium an increase in resistance to the combination amoxicillin/clavulanic acid of Escherichia coli as reference bacteria?].

Yourassowsky E, Van der Linden MP, MacGilavry GB, Glupczynsky Y.

Acta Clin Belg. 1992;47(1):15-20. French.

PMID:
1317079
34.

Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1991;37(1):38-42.

PMID:
2013240
35.

Antibacterial effect of meropenem and imipenem on Proteus mirabilis.

Yourassowsky E, Van der Linden MP, Crokaert F.

J Antimicrob Chemother. 1990 Aug;26(2):185-92.

PMID:
2211455
36.

Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

Yourassowsky E, van der Linden MP, Crokaert F.

Antimicrob Agents Chemother. 1990 Apr;34(4):505-9. Erratum in: Antimicrob Agents Chemother 1990 Aug;34(8):1622.

37.

Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Chemotherapy. 1990;36(3):215-21.

PMID:
2159865
38.

One shot of high-dose amikacin: a working hypothesis.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1990;36(1):1-7.

PMID:
2106415
39.

Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis.

Debets JM, Ruers TJ, van der Linden MP, van der Linden CJ, Buurman WA.

Clin Exp Immunol. 1989 Nov;78(2):224-9.

40.

Bactericidal activity of meropenem against Pseudomonas aeruginosa.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1989 Sep;24 Suppl A:169-74.

PMID:
2509414
41.

Plasma tumor necrosis factor and mortality in critically ill septic patients.

Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ.

Crit Care Med. 1989 Jun;17(6):489-94.

PMID:
2721208
42.

Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F.

J Chemother. 1989 May;1 Suppl 2:49-53.

PMID:
2681561
43.

The Pseudomonas oleovorans alkBAC operon encodes two structurally related rubredoxins and an aldehyde dehydrogenase.

Kok M, Oldenhuis R, van der Linden MP, Meulenberg CH, Kingma J, Witholt B.

J Biol Chem. 1989 Apr 5;264(10):5442-51.

44.

The Pseudomonas oleovorans alkane hydroxylase gene. Sequence and expression.

Kok M, Oldenhuis R, van der Linden MP, Raatjes P, Kingma J, van Lelyveld PH, Witholt B.

J Biol Chem. 1989 Apr 5;264(10):5435-41.

45.

Correlation between the growth and killing curves of Escherichia coli in the presence of cefotetan or piperacillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Chemotherapy. 1989;35(1):12-6.

PMID:
2656117
46.

Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1989;35(6):423-30.

PMID:
2515040
47.

Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Antimicrob Agents Chemother. 1988 Nov;32(11):1632-5.

48.

Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1988 Oct;22 Suppl D:43-7.

PMID:
3144548
49.

Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.

Crokaert F, Lismont MJ, van der Linden MP, Yourassowsky E.

J Clin Microbiol. 1988 Oct;26(10):2069-76.

50.

Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):433-4. No abstract available.

PMID:
3137055

Supplemental Content

Loading ...
Support Center